Vivaldi Capital Management LP Abbott Laboratories Transaction History

Vivaldi Capital Management LP

$340 Million
Q3 2024

A detailed history of Vivaldi Capital Management LP transactions in Abbott Laboratories stock. As of the latest transaction made, Vivaldi Capital Management LP holds 8,832 shares of ABT stock, worth $1.02 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

8,832

Previous 8,517 3.7%

Holding current value

$1.02 Million

Previous $885,000 13.67%

% of portfolio

0.3%

Previous 0.25%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $31,522 - $37,210	315 Added 3.7%	8,832 $1.01 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $19,944 - $22,263	198 Added 2.38%	8,517 $885,000
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $136,461 - $150,716	-1,246 Reduced 13.03%	8,319 $945,000
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $70,799 - $86,664	785 Added 8.94%	9,565 $1.05 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $16,622 - $19,943	-174 Reduced 1.94%	8,780 $850,000
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $38,800 - $43,231	385 Added 4.49%	8,954 $976,000
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $3,583 - $4,218	-37 Reduced 0.43%	8,569 $867,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $22,053 - $25,872	232 Added 2.77%	8,606 $945,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $8,805 - $10,194	91 Added 1.1%	8,374 $852,000
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $2,143 - $2,590	-21 Reduced 0.25%	8,283 $900,000
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $48,116 - $58,674	422 Added 5.35%	8,304 $912,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $8,433 - $10,326	-73 Reduced 0.92%	7,882 $1.11 Million
Q3 2021 Nov 16, 2021	BUY	$116.66 - $129.06 $116 - $129	1 Added 0.01%	7,955 $940,000
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $52,789 - $62,140	-499 Reduced 5.9%	7,954 $979,000
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $102,744 - $121,049	-944 Reduced 10.05%	8,453 $1 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $42,105 - $45,882	-401 Reduced 4.09%	9,397 $1.03 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $30,516 - $37,059	-333 Reduced 3.29%	9,798 $1.1 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $311,793 - $399,056	-4,072 Reduced 28.67%	10,131 $1.02 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $15,767 - $23,056	251 Added 1.8%	14,203 $1.12 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $100,963 - $112,396	-1,286 Reduced 8.44%	13,952 $1.21 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $37,891 - $41,086	463 Added 3.13%	15,238 $1.28 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $47,007 - $54,825	645 Added 4.56%	14,775 $1.24 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $478,571 - $578,593	7,227 Added 104.69%	14,130 $1.13 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $452,560 - $512,685	6,903 New	6,903 $499,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivaldi Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Vivaldi Capital Management LP with notifications on news.

Account

Vivaldi Capital Management LP Abbott Laboratories Transaction History